ADUS241220C90000
- 0.00
- 0.000.00%
Addus HomeCare Newsroom
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Addus HomeCare Initiated at Market Outperform by JMP Securities
JMP Securities Initiates Addus HomeCare(ADUS.US) With Buy Rating, Announces Target Price $150
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Addus Homecare (ADUS)
Is It Too Late To Consider Buying Addus HomeCare Corporation (NASDAQ:ADUS)?
BofA Securities Maintains Addus HomeCare(ADUS.US) With Buy Rating, Announces Target Price $147
Insider Sale: EVP & Chief HR Officer of $ADUS (ADUS) Sells 2,250 Shares
Strategic Acquisition Boosts Addus Homecare's Market Share and Financial Outlook
Strong Revenues Pushed Addus Homecare Corporation (ADUS) In Q3
Addus HomeCare (ADUS) Upgraded to Buy: Here's What You Should Know
ADUS Vs. ASTH: Which Stock Is the Better Value Option?
Press Release: Addus HomeCare Completes Acquisition of Personal Care Operations of Gentiva
Addus HomeCare Completes Acquisition Of Personal Care Operations Of Gentiva >ADUS
Addus HomeCare Corporation's (NASDAQ:ADUS) Shareholders Might Be Looking For Exit
RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $136
RBC Capital Reaffirms Their Buy Rating on Addus Homecare (ADUS)
Addus HomeCare's (NASDAQ:ADUS) One-year Total Shareholder Returns Outpace the Underlying Earnings Growth
Addus HomeCare to Participate in Stephens Annual Investment Conference
Addus HomeCare's (NASDAQ:ADUS) Promising Earnings May Rest On Soft Foundations